A review of the biology of bovine herpesvirus type 1 (BHV-1), its role as a cofactor in the bovine respiratory disease complex and development of improved vaccines

Animal Health Research Reviews

Volumn 8, Issue 2, 2007, Pages 187-205

  Jones, Clinton ^a   Chowdhury, Shafiqul ^b  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b KANSAS STATE UNIVERSITY   (United States)

Author keywords

bovine herpesvirus type 1 (BHV 1); bovine respiratory disease complex (BRDC); immune suppression; latency; pathogenesis; pneumonia

Indexed keywords

HERPES VACCINE; VIRUS PROTEIN;

ANIMAL; ANIMAL DISEASE; APOPTOSIS; CATTLE; CATTLE DISEASE; GENETICS; HERPES VIRUS INFECTION; IMMUNOLOGY; INFECTIOUS BOVINE RHINOTRACHEITIS VIRUS; METABOLISM; MUTATION; PATHOGENICITY; REVIEW; TRIGEMINUS GANGLION; VIROLOGY; VIRUS ACTIVATION; VIRUS LATENCY;

ANIMALS; APOPTOSIS; BOVINE RESPIRATORY DISEASE COMPLEX; CATTLE; CATTLE DISEASES; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, BOVINE; HERPESVIRUS VACCINES; MUTATION; TRIGEMINAL GANGLION; VIRAL PROTEINS; VIRUS ACTIVATION; VIRUS LATENCY;

EID: 41249086507     PISSN: 14662523     EISSN: 14752654     Source Type: Journal    
DOI: 10.1017/S146625230700134X     Document Type: Review

References (231)

1. Abril C, Engels M, Limman A, Hilbe M, Albini S, Franchini M, Suter M and Ackerman M (2004). Both viral and host factors contribute to neurovirulence of bovine herpesvirus 1 and 5 in interferon receptor-deficient mice. Journal of Virology 78: 3644-3653.
2. Ackermann M, Peterhans E and Wyler R (1982). DNA of bovine herpesvirus type 1 in the trigeminal ganglia of latently infected calves. American Journal of Veterinary Research 43: 36-40.
3. Ackermann M and Wyler R (1984). The DNA of an IPV strain of bovid herpesvirus 1 in sacral ganglia during latency after intravaginal infection. Veterinary Microbiology 9: 53-63.
4. Ackermann M and Engels M (2005). Pro and contra-IBR-eradication. Veterinary Microbiology 113: 293-302.
5. Ahmed M, Lock M, Miller CG and Fraser NW (2002). Regions of the herpes simplex virus type 1 latency-associated transcript that protect cells from apoptosis in vitro and protect neuronal cells in vivo. Journal of Virology 76: 717-729.
6. Ahn K, Meyer TH, Uebel S, Sempe P, Djaballah H, Yang Y, Peterson PA, Fruh K and Tampe R (1996). Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47. EMBO Journal 15: 3247-3255.
7. Alimonti JB, Shi L, Baijal PK and Greenberg AH (2001). Granzyme B induces BID-mediated cytochrome c release and mitochondrial permeability transition. Journal of Biological Chemistry 276: 6974-6982.
8. Amadori M, Archetti LL, Vernadi R and Berneri C (1992). Target recognition by bovine mononuclear, MHC-untreated cytotoxic cells. Veterinary Microbiology 33: 383-392.
9. Ambagala AP, Gopinath RS and Srikumaran S (2004). Peptide transport activity of the transporter associated with antigen processing (TAP) is inhibited by an early protein of equine herpesvirus-1. Journal of General Virology 66: 2383-2394.
10. Androlewicz MJ, Anderson KS and Cresswell P (1993). Evidence that transporters associated with antigen processing translocate a major histocompatibility complex class I-binding peptide into the endoplasmic reticulum in an ATP-dependent manner. Proceedings of the National Academy of Sciences, USA 90: 9130-9134.
11. Babiuk LA, Bielefeldt Ohamnn H, Gifford H, Czarniecki CW, Scialli VT and Hamilton EB (1985). Effect of bovine alpha 1 interferon on bovine herpesvirus type 1 induced respiratory disease. Journal of General Virology 66: 2383-2394.
12. Baranowski E, Dubuisson J, van Drunen Littel-van den Hurk S, Babiuk LA, Michel A, Pastoret PP and Thiry E (1995). Synthesis and processing of bovine herpesvirus-1 glycoprotein H. Virology 206: 651-654.
13. Baranowski E, Keil G, Lyaku J, Rijsewijk F, Van Oirschot J, Pastoret PP and Thiry E (1996). Structural and functional analysis of bovine herpesvirus 1 minor glycoproteins. Veterinary Microbiology 53: 91-101.
14. Barry M, Heibein JA, Pinkoski MJ, Lee SF, Moyer RW, Green DR and Bleackley RC (2000). Granzyme B short-circuits the need for caspase 8 activity during granule-mediated cytotoxic T-lymphocyte killing by directly cleaving Bid. Molecular and Cellular Biology 20: 3781-3794.
15. Borchers K, Wolfinger U and Ludwig H (1999). Latency-associated transcript of equine herpesvirus 4 in trigeminal ganglia of naturally infected horses. Journal of General Virology 80: 2165-2171.
16. Boutell C and Everett RD (2003). The herpes simplex virus type 1 (HSV-1) regulatory protein ICP0 interacts with an ubiquitinates p53. Journal of Biological Chemistry 278: 36596-36602.
17. Boutell C, Sadis S and Everett RD (2002). Herpes simplex virus type 1 immediate-early protein ICP0 and its isolated RING finger domain act as ubiquitin E3 ligases in vitro. Journal of Virology 76: 841-850.
18. Bowland SL and Shewen PE (2000). Bovine respiratory disease: commercial vaccines currently available in Canada. Canadian Veterinary Journal 41: 33-48.
19. Brack AR, Dijkstra JM, Granzow H, Klupp BG and Mettenleiter TC (1999). Inhibition of virion maturation by simultaneous deletion of glycoproteins E, I, and M of pseudorabies virus. Journal of Virology 73: 5364-5372.
20. Bratanich AC, Hanson ND and Jones C (1992). The latency-related gene of bovine herpesvirus 1 inhibits the activity of immediate-early transcription unit 1. Virology 191: 988-991.
21. Braun RP, Babiuk LA, Loehr BI and van Drunen Littel-van den Hurk S (1999). Particle-mediated DNA immunization of cattle confers long-lasting immunity against bovine herpesvirus-1. Virology 265: 46-56.
22. Brideau AD, Banfield BW and Enquist LW (1998). The Us9 gene product of pseudorabiesvirus, an alphaherpesvirus, is a phosphorylated, tail-anchored type II membrane protein. Journal of Virology 72: 4560-4570.
23. Brown GA and Field HJ (1990). Experimental reactivation of bovine herpesvirus 1 (BHV-1) by means of corticosteroids in an intranasal rabbit model. Archives of Virology 112: 81-101.
24. Bryant NA, Davis-Poynter N, Vanderplasschen A and Alcami A (2003). Glycoprotein G isoforms from some alphaherpes-virus function as broad-spectrum chemokine binding proteins. EMBO Journal 22: 833-846.
25. Butchi NB, Jones C, Perez S, Doster A and Chowdhury SI (2007). Envelope protein Us9 is required for the anterograde transport of bovine herpesvirus-1 (BHV-1) from trigeminal ganglia to nose and eye upon reactivation. Journal of Neurovirology 13: 384-388.
26. Campadelli-Fiume G and Gianni T (2006). HSV glycoproteins and their roles in virus entry and egress. In: Sandri-Goldin RM (ed.) Alpha Herpesviruses: Molecular and Cellular Biology. Portland, OR: International Specialized Book Service, pp. 135-156.
27. Campadelli-Fiume G, Cocchi GH and Menotti L (2000). The novel receptors that mediate the entry of herpes simplex viruses and animal alphaherpesviruses into cells. Reviews in Medical Virology 10: 305-319.
28. Campadelli-Fiume G, Amasio M, Avitabile E, Cerretani A, Forghieri C, Gianni T and Menotti L (2007). The multipartite system that mediates entry of herpes simplex virus into the cell. Reviews in Medical Virology 17: 313-326.
29. Campos M and Rossi CR (1986). Cytotoxicity of Bovine lymphocytes after treatment with lymphokines. American Journal of Veterinary Research 47: 1524-1528.
30. Campos M, Bielefeldt OH, Hutchings D, Rapin N and Babiuk LA (1989). Role of interferon gamma in inducing cytotoxicity of peripheral blood mononuclear leukocytes to bovine herpesvirus type 1 (BHV-1)-infected cells. Cellular Immunology 120: 259-269.
31. Cantin EM, Hinton DR, Chen J and Openshaw H (1995). Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1. Journal of Virology 69: 4898-4905.
32. Carter JJ, Weinberg AD, Pollard A, Reeves R, Magnuson JA and Magnuson NS (1989). Inhibition of T-lymphocyte mitogenic responses and effects on cell functions by bovine herpesvirus 1. Journal of Virology 63: 1525-1530.
33. Caselli E, Boni M, Di Luca D, Salvatori D, Vita A and Cassai E (2005). A combined bovine herpesvirus 1 gB-gD DNA vaccine induces immune response in mice. Comparative Immunology, Microbiology and Infectious Diseases 28: 155-166.
34. Cheung AK (1995). Investigation of pseudorabies virus DNA and RNA in trigeminal ganglia and tonsil tissues of latently infected swine. American Journal of Veterinary Research 56: 45-50.
35. Chowdhury SI (1996). Construction and characterization of an attenuated bovine herpesvirus type 1 (BHV-1) recombinant virus. Veterinary Microbiology 52: 13-23.
36. Chowdhury SI, Ross CSD, Lee BJ, Hall V and Chu H-J (1999). Construction and characterization of a glycoprotein E gene-deleted bovine herpesvirus type 1 recombinant. American Journal of Veterinary Research 60: 227-232.
37. Chowdhury SI, Lee BJ, Ozkul A and Weiss ML (2000). Bovine herpesvirus type-5 (BHV-5) glycoprotein E (gE) is important for neuroinvasiveness and neurovirulence in the olfactory pathway of the rabbit. Journal of Virology 74: 2094-2106.
38. Chowdhury SI, Mahmood S, Simon J, Al-Mubarak A and Zhou Y (2006). The Us9 gene encoded by bovine herpesvirus type 1 (BHV-1) effectively complements a Us9-null bovine herpesvirus 5 (BHV-5) for anterograde transport, neurovirulence and neuroinvasiveness in a rabbit model. Journal of Virology 80: 4396-4405.
39. Ciacci-Zanella J, Stone M, Henderson G and Jones C (1999). The latency-related gene of bovine herpesvirus 1 inhibits programmed cell death. Journal of Virology 73: 9734-9740.
40. Cook CB and Splitter GA (1989). Characterization of bovine mononuclear cell population with natural cytotoxic activity against bovine herpesvirus-1 infected cells. Cellular Immunology 120: 240-249.
41. Cunningham AL and Mikloska Z (2001). The Holy Grail: immune control of human herpes simplex virus infection and disease. Herpes 8 (suppl. 1): 6A-10A.
42. D'Arce RCF, Almedia RS, Silva TC, Spilki AC, Roehe PM and Ams CW (2002). Restriction endonucleases and monoclonal antibody analysis of Brazilian isolates of bovine herpesvirus 1 and 5. Veterinary Microbiology 88: 315-334.
43. Dasika GK and Letchworth GJ (1999). Cellular expression of bovine herpesvirus gD inhibits cell to cell spread of two closely related viruses without blocking their primary infection. Virology 254: 24-36.
44. Denis M, Slaoui M, Keil GM, Babiuk LA, Ernst E, Pastorer PP and Thiry E (1993). Identification of different target glycoproteins for bovine herpesvirus-1-specific cytotoxic T lymphocytes depending on the method of in vitro stimulation. Immunology 78: 7-13.
45. Deshpande MS, Ambagala TC, Hegde NR, Hariharan MJ, Navaratnam M and Srikumaran S (2002). Induction of cytotoxic T-lymphocytes specific for bovine herpesvirus-1 by DNA immunization. Vaccine 20: 3744-3751.
46. Devireddy LR and Jones C (1998). Alternative splicing of the latency-related transcript of bovine herpesvirus 1 yields RNAs containing unique open reading frames. Journal of Virology 72: 7294-7301.
47. Devireddy LR and Jones C (1999). Activation of caspases and p53 by bovine herpesvirus 1 infection results in programmed cell death and efficient virus release. Journal of Virology 73: 3778-3788.
48. Devireddy L, Zhang Y and Jones C (2003). Cloning and initial characterization of an alternatively spliced transcript encoded by the bovine herpes virus 1 latency related (LR) gene. Journal of Neurovirology 9: 612-622.
49. Dia L, Zhang B, Fan J, Gao X, Sun S, Yang K, Xin D, Jin N, Geng Y and Wang C (2005). Herpes virus proteins ICP0 and BICP0 can activate NF-kB by catalyzing IkBa ubiquitina-tion. Cellular Signalling 17: 217-229.
50. Dingwell KS and Johnson DC (1998). The herpes simplex virus gE-gI complex facilitates cell-to-cell spread and binds to components of cell junctions. Journal of Virology 72: 8933-8942.
51. Edwards S, White H and Nion P (1990). A study of the predominant genotypes of bovine herpesvirus 1 isolated in the UK. Veterinary Microbiology 22: 213-223.
52. Ellis J, Waldner C, Rhodes C and Ricketts V (2005). Longevity of protective immunity to experimental bovine herpesvirus-1 infection following inoculation with a combination modi-fied-live virus vaccine in beef calves. Journal of American Veterinary Medical Association 227: 123-128.
53. Endsley JJ, Quade MJ, Terhaar B and Roth JA (2002). BHV-1 specific CD4+, CD8+, and y8 T cells in calves vaccinated with one dose of a modified live BHV-1 vaccine. Viral Immunology 15: 385-393.
54. Enquist LW, Husak PJ, Banfield BW and Smith GA (1999). Spread of alpha herpesviruses in the nervous system. Advances in Virus Research 51: 237-347.
55. Everett RD (1987). A detailed mutational analysis of Vmw110, a trans-acting transcriptional activator encoded by herpes simplex virus type 1. EMBO Journal 6: 2069-2076.
56. Everett RD (1988). Analysis of the functional domains of herpes simplex virus type 1 immediate-early polypeptide Vmw110. Journal of Molecular Biology 202: 87-96.
57. Everett RD (2000). ICP0, a regulator of herpes simplex virus during lytic and latent infection [In Process Citation]. BioEssays 22: 761-770.
58. Everett RD, Barlow P, Milner A, Luisi B, Orr A, Hope G and Lyon D (1993). A novel arrangement of zinc-binding residues and secondary structure in the C3HC4 motif of an alpha herpes virus protein family. Journal of Molecular Biology 234: 1038-1047.
59. Everett RD, Meredith M, Orr A, Cross A, Kathoria M and Parkinson J (1997). A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein [corrected and republished from EMBO Journal (1997) 16: 566-577. EMBO Journal 16: 1519-1530.
60. Everett RD, Earnshaw WC, Findlay J and Lomonte P (1999a). Specific destruction of kinetochore protein CENP-C and disruption of cell division by herpes simplex virus immediate-early protein Vmw110. EMBO Journal 18: 1526-1538.
61. Everett RD, Lomonte P, Sternsdorf T, van Driel R and Orr A (1999b). Cell cycle regulation of PML modification and ND10 composition. Journal of Cell Science 112: 4581-4588.
62. Fehler F, Herrman JM, Saalmuller A, Mettenleiter TC and Keil GM (1992). Glycoprotein IV of bovine herpesvirus 1-expressing cell line complements and rescues a conditionally lethal viral mutant. Journal of Virology 66: 831-839.
63. Feldman LT, Ellison AR, Voytek CC, Yang L, Krause P and Margolis TP (2002). Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice. Proceedings of the National Academy of Sciences, USA 99: 978-983.
64. Fitzgerald KA, McWhirter SM, Faja KL, Rowe DC, Latz E, Golenbock DT, Coyle AJ, Liao S-M and Maniatis T (2003). IKKe and TBKI are essential components of the IRF3 signaling pathway. Nature 4: 491-496.
65. Fraefel C, Zeng J, Choffat Y, Engels M, Schwyzer M and Ackermann M (1994). Identification and zinc dependence of the bovine herpesvirus 1 transactivator protein BICP0. Journal of Virology 68: 3154-3162.
66. Fuchs M, Hubert P, Detterer J and Rziha HJ (1999). Detection of bovine herpesvirus type 1 in blood from naturally infected cattle by using a sensitive PCR that discriminates between wild-type virus and virus lacking glycoprotein E. Journal of Clinical Microbiology 37: 2498-2507.
67. Geiser V and Jones C (2003). Stimulation of bovine herpesvirus 1 productive infection by the adenovirus E1A gene and a cell cycle regulatory gene, E2F-4. Journal of General Virology 84: 929-938.
68. Geiser V and Jones C (2005). The latency related gene encoded by bovine herpesvirus 1 encodes a small regulatory RNA that inhibits cell growth. Journal of Neurovirology 11: 563-570.
69. Geiser V, Inman M, Zhang Y and Jones C (2002). The latency related (LR) gene of bovine herpes virus 1 (BHV-1) can inhibit the ability of bICP0 to activate productive infection. Journal of General Virology 83: 2965-2971.
70. Grant IR (2005). Zoonotic potential of Mycobacterium avium ssp. paratuberculosis: the current position. Journal of Applied Microbiology 98: 1282-1293.
71. Greene LA and Tischler AS (1976). Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proceedings of the National Academy of Sciences, USA 73: 2424-2428.
72. Greene LA, Aletta JM, Rukenstein A and Green SH (1987). PC12 pheochromocytoma cells: culture, nerve growth factor treatment, and experimental exploitation. Methods in Enzymology 147: 207-216.
73. Griebel P, Qualtiere L, Davis WC, Gee A, Bielefeldt Ohmann H, Lawman MJ and Babiuk LA (1987a). T lymphocyte population dynamics and function following a primary bovine herpesvirus type-1 infection. Viral Immunology 1: 287-304.
74. Griebel PJ, Qualtiere L, Davis WC, Lawman MJ and Babiuk LA (1987b). Bovine peripheral blood leukocyte subpopulation dynamics following a primary bovine herpesvirus-1 infection. Viral Immunology 1: 267-286.
75. Griebel P, Ohmann HB, Lawman MJ and Babiuk LA (1990). The interaction between bovine herpesvirus type 1 and activated bovine T lymphocytes. Journal of General Virology 71: 369-377.
76. Guo J, Peters KL, and Sen GC (2000). Induction of the human protein P56 by interferon, double stranded RNA, or virus infection. Virology 267: 209-219.
77. Halford WP, Gebhardt BM and Carr DJ (1996). Persistent cytokine expression in trigeminal ganglion latently infected with herpes simplex virus type 1. Journal of Immunology 157: 3542-3549.
78. Hanon E, Meyer G, Vanderplasschen A, Dessy-Doize C, Thiry E and Pastoret PP (1998). Attachment but not penetration of bovine herpesvirus 1 is necessary to induce apoptosis in target cells. Journal of Virology 72: 7638-7641.
79. Hariharan MJ, Nataraj C and Srikumaran SS (1993). Down regulation of murine MHC class I expression by bovine herpesvirus 1. Viral Immunology 6: 273-284.
80. Harwood A and Bragga VMM (2003). Cdc42 and GSK-3: signals at the crossroads. Nature Cell Biology 5: 275-277.
81. Henderson G, Perng G-C, Nesburn A, Wechsler S and Jones C (2004). The latency related gene of bovine herpesvirus 1 can suppress caspase 3 and caspase 9 during productive infection. Journal of Neurovirology 10: 64-70.
82. Henderson G, Zhang Y and Jones C (2005). The bovine herpesvirus 1 gene encoding infected cell protein 0 (bICP0) can inhibit interferon-dependent transcription in the absence of other viral genes. Journal of General Virology 86: 2697-2702.
83. Hinkley S, Hill AB and Srikumaran S (1998). Bovine herpesvirus-1 infection affects the peptide transport activity in bovine cells. Virus Research 53: 91-96.
84. Homan EJ and Easterday BC (1983). Experimental latent and recrudescent bovine herpesvirus-1 infections in calves. American Journal of Veterinary Research 44: 309-313.
85. Honda K, Yanai H, Negishi H, Asagiri M, Saton M, Mizutani T, Shimada N, Ohba Y, Takaoka A, Yoshida N and Taniguchi T (2005). IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434: 772-777.
86. Hossain A, Schang LM and Jones C (1995). Identification of gene products encoded by the latency-related gene of bovine herpesvirus 1. Journal of Virology 69: 5345-5352.
87. Huang Y, Babiuk LA and van Drunen Littel-van den Hurk S (2005). Immunization with a bovine herpesvirus-1 glycoprotein B DNA vaccine induces cytotoxic T lymphocyte responses in mice and cattle. Journal of General Virology 88: 887-898.
88. Huang J, Liao G, Chen H, Wu FY, Hutt-Fletcher L, Hayward GS and Hayward SD (2006). Contribution of C/EBP proteins to Epstein-Barr virus lytic gene expression and replication in epithelial cells. Journal of Virology 80: 1098-1109.
89. Hughes EA, Hammond C and Cresswell P (1997). Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteosome. Proceedings of the National Academy of Sciences, USA 94: 1896-1901.
90. Hutchings DL, van Drunen Littel-van den Hurk S and Babiuk LA (1990). Lymphocyte proliferative responses to separated bovine herpesvirus 1 proteins in immune cattle. Journal of Virology 64: 5114-5122.
91. Inman M, Perng G-C, Henderson G, Ghiasi H, Nesburn AB, Wechsler SL and Jones C (2001a). Region of herpes simplex virus type 1 latency-associated transcript sufficient for wild-type spontaneous reactivation promotes cell survival in tissue culture. Journal of Virology 75: 3636-3646.
92. Inman M, Lovato L, Doster A and Jones C (2001b). A mutation in the latency-related gene of bovine herpesvirus 1 leads to impaired ocular shedding in acutely infected calves. Journal of Virology 75: 8507-8515.
93. Inman M, Zhang Y, Geiser V and Jones C (2001c). The zinc ring finger in the bICP0 protein encoded by bovine herpes virus-1 mediates toxicity and activates productive infection. Journal of General Virology 82: 483-492.
94. Inman M, Lovato L, Doster A and Jones C (2002). A mutation in the latency related gene of bovine herpesvirus 1 interferes with the latency-reactivation cycle of latency in calves. Journal of Virology 76: 6771-6779.
95. Inman M, Zhou J, Webb H and Jones C (2004). Identification of a novel transcript containing a small open reading frame that is expressed during latency, and is antisense to the latency related gene of bovine herpes virus 1 (BHV-1). Journal of Virology 78: 5438-5447.
96. Janssen EM, Lemmens EE, Wolfe T, Christen U, von Herrath MG and Schoenberger SP (2003). CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature 421: 852-856.
97. Jensen J and Schulz RD (1990). Bovine natural cell mediated cytotoxicity (NCMC): activation by cytokines. Veterinary Immunology and Immunopathology 24: 113-129.
98. Jiang Y, Hossain A, Winkler MT, Holt T, Doster A and Jones C (1998). A protein encoded by the latency-related gene of bovine herpesvirus 1 is expressed in trigeminal ganglionic neurons of latently infected cattle and interacts with cyclin-dependent kinase 2 during productive infection. Journal of Virology 72: 8133-8142.
99. Jiang Y, Inman M, Zhang Y, Posadas NA and Jones C (2004). A mutation in the latency related gene of bovine herpesvirus 1 (BHV-1) inhibits protein expression of a protein from open reading frame 2 (ORF-2) and an adjacent reading frame during productive infection. Journal of Virology 78: 3184-3189.
100. Jones C (1998). Alphaherpesvirus latency: its role in disease and survival of the virus in nature. Advances in Virus Research 51: 81-133.
101. Jones C (2003). Herpes simplex virus type 1 and bovine herpesvirus 1 latency. Clinical Microbiology Reviews 16: 79-95.
102. Jones C, Newby TJ, Holt T, Doster A, Stone M, Ciacci-Zanella J, Webster CJ and Jackwood MW (2000). Analysis of latency in cattle after inoculation with a temperature sensitive mutant of bovine herpesvirus 1 (RLB106). Vaccine 18: 3185-3195.
103. Jones C, Geiser V, Henderson G, Jiang Y, Meyer F, Perez S and Zhang Y (2006). Functional analysis of bovine herpesvirus 1 (BHV-1) genes expressed during latency. Veterinary Microbiology 113: 199-210.
104. Jons A, Dijkstra JM and Mettenleiter TC (1998). Glycoproteins M and N of pseudorabies virus form a disulfide-linked complex. Journal of Virology 72: 550-557.
105. Kaashoek MJ, van Engelenburg FAC, Moerman A, Gielkens ALJ, Fijsewijk FAM and van Oirschot JT (1996a). Virulence and immunogenicity in calves of thymidine kinase-and glycoprotein E-negative bovine herpesvirus 1 mutants. Veterinary Microbiology 48: 143-153.
106. Kaashoek MJ, Rijsewijk FA and Oirschot JT (1996b). Persistence of antibodies against bovine herpesvirus 1 and virus reactivation two to three years after infection. Veterinary Microbiology 53: 103-110.
107. Kaashoek MJ, Fijsewijk FAM, Ruuls RC, Keil GM, Thiry E, Pastoret PP and Van Oirschot JT (1998). Virulence, immunogenicity and reactivation of bovine herpesvirus 1 mutants with a deletion in the gC, gG, gI, gE, or in both the gI and gE gene. Vaccine 16: 802-809.
108. Kagi D and Hengartner H (1996). Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses. Current Opinion in Immunology 8: 472-477.
109. Kanamoto T, Mota M, Takeda K, Rubin LL, Miyazono K, Ichijo H and Bazenet CE (2000). Role of apoptosis signal-regulating kinase in regulation of the c-Jun N-terminal kinase pathway and apoptosis in sympathetic neurons. Molecular and Cellular Biology 20: 196-204.
110. Khattar SK, van Drunen Littel-van den Hurk S, Attah-Poku SK, Babiuk LA and Tikoo SK (1996). Identification and characterization of a bovine herpesvirus-1 (BHV-1) glycoprotein gL which is required for proper antigenicity, processing, and transport of BHV-1 glycoprotein gH. Virology 219: 66-76.
111. Koch J, Gruntrum R, Heintke S, Kyritisis C and Tampe R (2004). Functional dissection of the transmembrane domains of the transporter associated with antigen processing (TAP). Journal of Biological Chemistry 279: 10142-10147.
112. Kcinig P, Giesow K and Keil GM (2002). Glycoprotein M of bovine herpesvirus 1 (BHV-1) is nonessential for replication in cell culture and is involved in inhibition of bovine respiratory syncytial virus F protein induced syncytium formation in recombinant BHV-1 infected cells. Veterinary Microbiology 86: 37-49.
113. Koppers-Lalic D, Reits EAJ, Ressing ME, Lipinska AD, Abele R, Koch J, Rezende MM, Admiraal P, van Leeuwen D, Bienkowska-Szewczyk K, Mettenleiter TC, Rijsewijk FAM, Tampe R, Neefjes J. and Wiertz EJHJ (2005). Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing. Proceedings of the National Academy of Sciences, USA 102: 5144-5149.
114. Kutish G, Mainprize T and Rock D (1990). Characterization of the latency-related transcriptionally active region of the bovine herpesvirus 1 genome. Journal of Virology 64: 5730-5737.
115. Kweon C-H, Kang S-W, Choi E-J and Kang Y-B (1999). Bovine herpesvirus expressing envelope protein (E2) of bovine viral diarrhea virus as a vaccine candidate. Journal of Veterinary Medical Science 61: 395-401.
116. Lawman MJP, Gifford G, Gyongyossy-Issa M, Dragan R, Heise J and Babiuk LA (1987). Activity of polymorphonuclear (PMN) leukocytes diseases bovine herpesvirus-1 induced respiratory disease: effect of recombinant bovine interferon alpha I. Antiviral Research 8: 225-238.
117. Leary TP and Splitter GA (1990). Recombinant herpesviral proteins produced by cell-free translation provide a novel approach for the mapping of T lymphocyte epitopes. Journal of Immunology 145: 718-723.
118. Li H, Zhu H, Xu CJ and Yuan J (1998). Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94: 491-501.
119. Li Y, Van Drunen Littel-van den Hurk S, Babiuk LA and Liang X (1995). Characterization of cell-binding properties of bovine herpesvirus 1 glycoproteins B, C and D: identification of a dual cell binding function of gB. Journal of Virology 69: 4758-4768.
120. Liang X, Tang M, Manns B, Babiuk LA and Zamb TJ (1993). Identification and deletion mutagenesis of the bovine herpesvirus 1 dUTPase gene and a gene homologous to herpes simplex virus UL49.5. Virology 195: 42-50.
121. Liang X, Chow B, Raggo C and Babiuk LA (1996). Bovine herpesvirus 1 UL49.5 homolog gene encodes a novel viral envelope protein that forms a disulfide-linked complex with a second virion structural protein. Journal of Virology 70: 1448-1454.
122. Lipiinska AD, Koppers-Lalic D, Rychlowski M, Admiraal P, Rijsewijk FAM, Bienkowska-Szewczyk K and Wiertz EJHJ (2006). Bovine herpesvirus 1 UL49.5 protein inhibits the transporter associated with antigen processing despite complex formation with glycoprotein M. Journal of Virology 81: 5822-5832.
123. Liu T, Tang Q and Hendricks RL (1996). Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection. Journal of Virology 70: 264-271.
124. Liu T, Khanna KM, Chen X, Fink DJ and Hendricks RL (2000). CD8(+) T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. Journal of Experimental Medicine 191: 1459-1466.
125. Liu T, Khanna KM, Carriere BN and Hendricks RL (2001). Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons. Journal of Virology 75: 11178-11184.
126. Liu Z, Coats C, Jones C and Chowdhury SI (2007). Construction and characterization of BHV-1 glycoprotein E (gE) cytoplasmic tail truncated and Us9 acidic domain deleted mutants. In: 32nd International Herpesvirus Workshop, Asheville, NC, USA. Abstract no. 3.36.
127. Marshall RL, Israel BA and Letchworth GJ (1988). Monoclonal antibody analysis of bovine herpesvirus-1 glycopro antigenic areas relevant to natural infection. Virology 165: 338-347.
128. Maul GG and Everett RD (1994). The nuclear location of PML, a cellular member of the C3HC4 zinc-binding domain protein family, is rearranged during herpes simplex virus infection by the C3HC4 viral protein ICP0. Journal of General Virology 75: 1223-1233.
129. Maul GG, Guldner HH and Spivack JG (1993). Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICP0). Journal of General Virology 74: 2679-2690.
130. Mettenleiter TC (2000). Aujeszky's disease (pseudorabies) virus: the virus and molecular pathogenesis-state of the art. Veterinary Research 31: 99-115.
131. Mettenleiter TC (2002). Brief overview on cellular virus receptors. Virus Research 82: 3-8.
132. Metzler AE, Matile H, Gasman U, Engels M and Wyler R (1985). European isolates of bovine herpesvirus 1: a comparison of restriction endonuclease sites, polypeptides and reactivity with monoclonal antibodies. Archives of Virology 85: 57-69.
133. Meyer G, Hanon E, Georlette D, Pastoret PP and Thiry E (1998). Bovine herpesvirus type 1 glycoprotein H is essential for penetration and propagation in cell culture. Journal of General Virology 79: 1983-1987.
134. Meyer F, Perez S, Geiser V, Sintek M, Inman M and Jones C (2007). A protein encoded by the bovine herpes virus 1 (BHV-1) latency related gene interacts with specific cellular regulatory proteins, including the CCAAT enhancer binding protein alpha (C/EBP-a). Journal of Virology 81: 59-67.
135. Mikloska Z and Cunningham AL (2001). Alpha and gamma interferons inhibit herpes simplex virus type 1 infection and spread in epidermal cells after axonal transmission. Journal of Virology 75: 11821-11826.
136. Milligan GN, Meador MG, Chu C, Young CG, Martin TL and Bourne N (2005). Long-term presence of virus-specific plasma cells in sensory ganglia and spinal cord following intravaginal inoculation of herpes simplex virus type 2. Journal of Virology 79: 11537-11540.
137. Misra V, Walker S, Hayes S and O'Hare P (1995). The bovine herpesvirus alpha gene trans-inducing factor activates transcription by mechanisms different from those of its herpes simplex virus type 1 counterpart VP16. Journal of Virology 69: 5209-5216.
138. Miyoshi M, Ishii Y, Takiguchi M, Takada A, Yasuda J, Hashimoto A, Okasaki K and Kida H (1999). Detection of canine herpesvirus DNA in ganglionic neurons and the lymph node lymphocytes of latently infected dogs. Journal of Veterinary Medical Science 61: 375-379.
139. Montgomery RI, Warner MS, Lum BJ and Spear PG (1996). Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87: 427-436.
140. Mossman KL, Macgregor PF, Rozmus JJ, Goryachev AB, Edwards AM and Smiley JR (2001). Herpes simplex virus triggers and then disarms a host antiviral response. Journal of Virology 75: 750-758.
141. Mott K, Osorio N, Jin L, Brick D, Naito J, Cooper J, Henderson G, Inman M, Jones C, Wechsler SL and Perng G-C (2003). The bovine herpesvirus 1 LR ORF2 is crucial for this gene's ability to restore the high reactivation phenotype to a Herpes simplex virus-1 LAT null mutant. Journal of General Virology 84: 2975-2985.
142. Mweene AS, Okazaki K and Kida H (1996). Detection of viral genome in non-neural tissues of cattle experimentally infected with bovine herpesvirus 1. Japanese Journal of Veterinary Research 44: 165-174.
143. Nakamichi K, Matsumota Y and Otsuka H (2002). Bovine herpesvirus 1 glycoprotein G is necessary for maintaining cell-to-cell junctional adherence among infected cells. Virology 294: 22-30.
144. Nash AA, Jayasuriya A, Phelan J, Cobbold SP, Waldmann H and Prospero T (1987). Different roles for L3T4+ and Lyt 2+ T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system. Journal of General Virology 68: 825-833.
145. NASS (1996). Agricultural Statistics Board. Summary of cost associated with bovine respiratory disease complex. Washington, DC: US Department of Agriculture.
146. Nataraj C, Eidmann S, Hariharan MJ, Sur JH, Perry GA and Srikumaran S (1997). Bovine herpesvirus 1 downregulates the expression of bovine MHC class I molecules. Viral Immunology 10: 21-34.
147. Ogita H and Takai Y (2006). Nectin and nectin-like molecules: roles in cell adhesion, polarization, movement, and proliferation. IUBMB Life 58: 334-343.
148. Oirschot JTV (1995). Bovine herpesvirus in semen of bulls and the risk of transmission: a brief overview. Veterinary Quartarly 17: 29-33.
149. Okazaki K, Matsuzaki T, Sugahara Y, Okada J, Hasebe M, Iwamura Y, Ohnishi M, Kanno T, Shimizu M, Honda E and Kono Y (1991). BHV-1 adsorption is mediated by the interaction of glycoprotein gIII with heparinlike moiety on the cell surface. Virology 181: 666-670.
150. Parkinson J and Everett RD (2000). Alphaherpesvirus proteins related to herpes simplex virus type 1 ICP0 affect cellular structures and proteins. Journal of Virology 74: 1000-610-017.
151. Perez S, Inman M, Doster A and Jones C (2005). Latency-related gene encoded by bovine herpesvirus 1 promotes virus growth and reactivation from latency in tonsils of infected calves. Journal of Clinical Microbiology 43: 393-401.
152. Perez S, Lovato L, Zhou J, Doster A and Jones C (2006). Comparison of inflammatory infiltrates in trigeminal ganglia of cattle infected with wild type BHV-1 versus a virus strain containing a mutation in the LR (latency-related) gene. Journal of Neurovirology 12: 392-397.
153. Perez S, Meyer F, Henderson G, Jiang Y, Sherman S, Doster A, Inman M and Jones C (2007). A protein encoded by the bovine herpesvirus 1 ORF E gene induces neurite-like morphological changes in mouse neuroblastoma cells and is expressed in trigeminal ganglionic neurons. Journal of Neurovirology 13: 139-149.
154. Perng G-C, Jones C, Ciacci-Zanella J, Stone M, Henderson G, Yukht A, Slanina SM, Hoffman FM, Ghiasi H, Nesburn AB and Wechsler SL (2000). Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript (LAT). Science 287: 1500-1503.
155. Perng G-C, Maguen B, Jin L, Mott KR, Osorio N, Slanina SM, Yukht A, Ghiasi H, Nesburn AB, Inman M, Henderson G, Jones C and Wechsler SL (2002). A gene capable of blocking apoptosis can substitute for the herpes simplex virus type 1 latency-associated transcript gene and restore wild-type reactivation levels. Journal of Virology 76: 1224-1235.
156. Pertel P, Fridberg A, Parish ML and Spear PG (2001). Cell fusion induced by herpes simplex virus glycoproteins gB, gD, and gH-gI, requires a gD receptor but not necessarily heparan sulfate. Virology 279: 313-324.
157. Peterhans E, Jungi TW and Schweizer M (2006). How the bovine viral diarrhea virus outwits the immune system. Deutsche Tierarztliche Wochenschrift 40: 124-129.
158. Pinkoski MJ, Waterhouse NJ, Heibein JA, Wolf BB, Kuwana T, Goldstein JC, Newmeyer DD, Bleackley RC and Green DR (2001). Granzyme B-mediated apoptosis proceeds predominantly through a Bcl-2-inhibitable mitochondrial pathway. Journal of Biological Chemistry 276: 1206-012-067.
159. eske A, Pollara G, Krummenacher C, Chain BM and Katz DR (2007). Understanding HSV-1 entry glycoproteins. Reviews in Medical Virology 17: 205-215.
160. Rock DL, Beam SL and Mayfield JE (1987). Mapping bovine herpesvirus type 1 latency-related RNA in trigeminal ganglia of latently infected rabbits. Journal of Virology 61: 3827-3831.
161. Rock D, Lokensgard J, Lewis T and Kutish G (1992). Characterization of dexamethasone-induced reactivation of latent bovine herpesvirus 1. Journal of Virology 66: 2484-2490.
162. Rossels V, Marche S, Roupie V, Govaerts M, Godfroid J, Walravens K and Huygen K (2006). Members of the 30-32-kilodalton mycolyl transferase family (Ag85) from culture filtrate of Mycobacterium avium subsp. paratuber-culosis are immunodominant Th1-type antigens recognized early upon infection in mice and cattle. Infection and Immunity 74: 202-212.
163. Rouse BT and Babiuk LA (1977). The direct antiviral cytotoxicity by bovine lymphocytes is not restricted by genetic incompatibility of lymphocytes and target cells. Journal of Immunology 118: 618-624.
164. Rouse BT and Babiuk LA (1978). Mechanism of recovery from herpesvirus infections. Canadian Journal of Comparative Medicine 42: 414-427.
165. Rouse BT, Wardley RC and Babiuk LA (1976). Antibody dependent cell-mediated cytotoxicity in cows: comparison of effector cell activity against heterologous erythrocytes and herpesvirus-infected bovine target cells. Infection and Immunity 13: 1433-1441.
166. Rouse BT, Grewal AS and Babiuk LA (1977a). Complement enhances antiviral antibody dependent cell toxicity. Nature 266: 456-458.
167. Rouse BT, Wardley RC and Babiuk LA (1977b). Enhancement of antibody dependent cell toxicity of herpesvirus infected cells by complement. Infection and Immunity 18: 660-665.
168. Rudolph J, Seyboldt C, Granzow H and Osterrieder N (2002). The gene 10 (UL49.5) product of equine herpesvirus 1 is necessary and sufficient for functional processing of glycoprotein M. Journal of Virology 76: 2952-2963.
169. Sabo A and Rajanci J (1976). Latent pseudorabies virus infection in pigs. Acta Virologica 20: 208-214.
170. Saira K, Zhou Y and Jones C (2007). The infected cell protein 0 encoded by bovine herpesvirus 1 (bICP0) induces degradation of interferon response factor 3 (IRF3), and consequently inhibits beta interferon promoter activity. Journal of Virology 81: 3077-3086.
171. Sakisaka T, Taniguchi T, Nakanishi H, Takahashi K, Miyahara M, Ikeda W, Yokoyama S, Peng YF, Yamanishi K and Takai Y (2001). Requirement of interaction of nectin-1 alpha/HveC with afadin for efficient cell-cell spread of herpes simplex virus type 1. Journal of Virology 75: 4734-4743.
172. Sato M, Taniguchi T and Tanaka N (2001). The interferon system and interferon regulatory factor transcription factors-studies from gene knockout mice. Cytokine and Growth Factor Reviews 12: 133-142.
173. Sausker EA and Dyer NW (2002). Seroprevalence of OHV-2, BVDV, BHV-1, and BRSV in ranch-raised bison (Bison bison). Journal of Veterinary Diagnostic Investigation 14: 68-70.
174. Schang L and Jones C (1997). Analysis of bovine herpesvirus 1 transcripts during a primary infection of trigeminal ganglia of cattle. Journal of Virology 71: 6786-6795.
175. Schang LM, Hossain A and Jones C (1996). The latency-related gene of bovine herpesvirus 1 encodes a product which inhibits cell cycle progression. Journal of Virology 70: 3807-3814.
176. Schmitz I, Kirchhoff S and Krammer PH (2000). Regulation of death receptor-mediated apoptosis pathways. International Journal of Biochemistry and Cell Biology 32: 1123-1136.
177. Schroder C, Linde G, Fehler F and Keil GM (1997). From essential to beneficial: glycoprotein D loses importance for replication of bovine herpesvirus 1 in cell culture. Virology 71: 25-33.
178. Schwyzer M and Ackermann M (1996). Molecular virology of ruminant herpesviruses. Veterinary Microbiology 53: 17-29.
179. Sharma S, ten Oever BR, Grandvaux N, Zhou G-P, Lin R and Hiscott J (2003). Trigering the interferon antiviral response through and IKK-related pathway. Science 300: 1148-1151.
180. Shedlock DJ and Shen H (2003). Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300: 337-339.
181. Sheffy BE and Davies DH (1972). Reactivation of a bovine herpesvirus after corticosteroid treatment. Proceedings of the Society for Experimental Biology and Medicine 140: 974-976.
182. Shimeld C, Whiteland JL, Nicholls SM, Grinfeld E, Easty DL, Gao H and Hill TJ (1995). Immune cell infiltration and persistence in the mouse trigeminal ganglion after infection of the cornea with herpes simplex virus type 1. Journal of Neuroimmunology 61: 7-16.
183. Shimeld C, Whiteland JL, Williams NA, Easty DL and Hill TJ (1996). Reactivation of herpes simplex virus type 1 in the mouse trigeminal ganglion: an in vivo study of virus antigen and immune cell infiltration. Journal of General Virology 77: 2583-2590.
184. Shimeld C, Whiteland JL, Williams NA, Easty DL and Hill TJ (1997). Cytokine production in the nervous system of mice during acute and latent infection with herpes simplex virus type 1. Journal of General Virology 78: 3317-3325.
185. Shresta S, Pham CT, Thomas DA, Graubert TA and Ley TJ (1998). How do cytotoxic lymphocytes kill their targets? Current Opinion in Immunology 10: 581-587.
186. Simmons A, Tscharke D and Speck P (1992). The role of immune mechanisms in control of herpes simplex virus infection of the peripheral nervous system. Current Topics in Microbiology and Immunology 179: 31-56.
187. Simmons A and Tscharke DC (1992). Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: implications for the fate of virally infected neurons. Journal of Experimental Medicine 175: 1337-1344.
188. Spear PG (1993). Entry of alphaherpesviruses into cells. Seminars in Virology 4: 167-180.
189. Spear PG (2004). Herpes simplex virus: receptors and ligands for cell entry. Cellular Microbiology 6: 401-410.
190. Spear PG and Longnecker R (2003). Herpesvirus entry: an update. Journal of Virology 77: 10179-10185.
191. Spear PG, Eisenberg RJ and Cohen GH (2000). Three classes of cell surface receptors for alphaherpesvirus entry. Virology 344: 17-24.
192. Spear PG, Manoj S, Yoon M, Jogger CR, Zago A and Myscofski D (2006). Different receptors binding to distinct interfaces on herpes simplex virus gD can trigger events leading to cell fusion and viral entry. Virology 344: 17-24.
193. Straub OC (1990). Infectious bovine rhinotracheitis virus. In: Morin ZdaB (ed.) Virus Infections of Ruminants. Amsterdam: Elsevier, pp. 71-109.
194. Straub OC and Ahl R (1976). Lokale interferonbildung beim rind nach intranasaler infektion mit avirulentem IBR-IPV-virus und deren wirkung auf eine anschliebende infection mit maul und klauenseuche-virus. Zentralblatt fur Veterinar-medizin B 23: 470-482.
195. Theil D, Derfuss T, Paripovic I, Herberger S, Meinl E, Schueler O, Strupp M, Arbusow V and Brandt T (2003). Latent herpesvirus infection in human trigeminal ganglia causes chronic immune response. American Journal of Pathology 163: 2179-2184.
196. Thriy E, Muylkens B, Meurens F, Gogev S, Thiry J, Vandel-plasschen A and Schynts F (2005). Recombination in the alphaherpesvirus bovine herpesvirus 1. Veterinary Microbiology 113: 171-177.
197. Tikoo SK, Campos M and Babiuk LA (1995a). Bovine herpesvirus 1 (BHV-1): biology, pathogenesis, and control. Advances in Virus Research 45: 191-223.
198. Tikoo SK, Campos M, Popowych YI, van Drunen Little-van den Hurk S and Babiuk LA (1995b). Lymphocyte proliferative responses to recombinant bovine herpesvirus virus type 1 (BHV-1) glycoprotein gD (gIV) in immune cattle: identification of a T cell epitope. Viral Immunology 8: 19-25.
199. Tomishama MJ and Enquist LW (2001). A conserved a-herpesvirus protein necessary for axonal localization of viral membrane proteins. Journal of Cell Biology 154: 741-752.
200. Turin L, Russo S and Poli G (1999). BHV-1: new molecular approaches to control a common and widespread infection. Molecular Medicine 5: 261-284.
201. Van Drunen Littel-van den Hurk S (2005). Rationale and perspectives on the success of vaccination against bovine herpesvirus-1. Veterinary Microbiology 113: 275-282.
202. Van Drunen Littel-van den Hurk S and Babiuk LA (1986). Polypeptide specificity of the antibody reponse after primary and recurrent infection with bovine herpesvirus 1. Journal of Clinical Microbiology 23: 274-282.
203. Van Drunen Littel-van den Hurk S, Tikoo SK, Liang X and Babiuk LA (1993). Bovine herpesvirus-1 vaccines. Immunology and Cell Biology 71: 405-420.
204. Van Drunen Littel-van den Hurk S, Braun RP, Lewis PJ, Karvonen BC, Baca-Estrada ME, Snider MM, Cartney D, Watts T and Babiuk LA (1998). Intradermal immunization with a bovine herpesvirus-1 DNA vaccine induces protective immunity in cattle. Journal of General Virology 79: 831-839.
205. Van Drunen Littel-van den Hurk S, Braun RP, Lewis PJ, Karvonen BC, Babiuk LA and Griebel PJ (1999). Immunization of neonates with DNA encoding a bovine herpesvirus glycoprotein is effective in the presence of maternal antibodies. Viral Immunology 12: 67-77.
206. Van Drunen Littel-van den Hurk S, Myers D, Doig PA, Karvonen B, Habermehl M, Babiuk LA, Jelinski M, Van Donkersgoed J, Schlesinger K and Rinehart C (2001). Identification of a mutant bovine herpesvirus-1 (BHV-1) in post-arrival outbreaks of IBR in feedlot calves and protection with conventional vaccination. Canadian Journal of Veterinary Research 65: 81-88.
207. Van Drunen Littel-van den Hurk S (2007). Cell-mediated immune responses induced by BHV-1: rational vaccine design. Expert Review of Vaccines 6: 369-380.
208. van Endert PM, Saveanu L, Hewitt EW and Lehner P (2002). Powering the peptide pump: TAP crosstalk with energetic nucleotides. Trends in Biochemical Science 27: 454-461.
209. Van Sant C, Hagglund R, Lopez P and Roizman B (2001). The infected cell protein 0 of herpes simplex virus 1 dynamically interacts with proteasomes, binds and activates the cdc34 E2 ubiquitin-conjugating enzyme, and possesses in vitro E3 ubiquitin ligase activity. Proceedings of the National Academy of Sciences, USA 98: 8815-8820.
210. Verjans GM, Hintzen RQ, van Dun JM, Poot A, Milikan JC, Laman JD, Langerak AW, Kinchington PR and Osteerhaus ADME (2007). Selective retention of herpes simplex virus-specific T cells in latently infected human trigeminal ganglia. Proceedings of the National Academy of Sciences, USA 104: 3496-3501.
211. Wakenshaw L, Walters MS and Whitehouse A (2005). The herpesvirus saimiri replication and transcription activator acts synergistically with CAAT enhancer binding protein alpha to activate the DNA polymerase promoter. Journal of Virology 79: 13548-13560.
212. Wang L, Whitbeck C, Lawrence WC, Volgin DV and Bello LJ (2003a). Expression of the genomic form of the bovine viral diarrhea virus E2 ORF in a bovine herpes-1 vector. Virus Research 27: 83-91.
213. Wang SE, Wu FY, Yu Y and Hayward GS (2003b). CCAAT/ enhancer-binding protein-alpha is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters. Journal of Virology 17: 9590-9612.
214. Wang X (2001). The expanding role of mitochondria in apoptosis. Genes and Development 15: 2922-2933.
215. Wathelet MG, Lin CH, Parekh BS, Ronco LV, Howley PM and Maniatis T (1998). Virus infection induces the assembly of coordinately activated transcription factors on the IFN-b enhancer in vivo. Molecular Cell 1: 507-518.
216. Whitbeck JC, Knapp AC, Enquist LW, Lawrence WC and Bello LJ (1996). Synthesis, processing, and oligomerization of the bovine herpes virus 1 gE and gI membrane proteins. Journal of Virology 70: 7878-7884.
217. Winkler MT, Doster A and Jones C (1999). Bovine herpesvirus 1 can infect CD4(+) T lymphocytes and induce programmed cell death during acute infection of cattle. Journal of Virology 73: 8657-8668.
218. Winkler MT, Doster A, Sur JH and Jones C (2002). Analysis of bovine trigeminal ganglia following infection with bovine herpesvirus 1. Veterinary Microbiology 86: 139-155.
219. Winkler MTC, Doster A and Jones C (2000). Persistence and reactivation of bovine herpesvirus 1 in the tonsil of latently infected calves. Journal of Virology 74: 5337-5346.
220. Wirth UV, Vogt B and Schwyzer M (1991). The three major immediate-early transcripts of bovine herpesvirus 1 arise from two divergent and spliced transcription units. Journal of Virology 65: 195-205.
221. Wirth UV, Fraefel C, Vogt B, Vlcek C, Paces V and Schwyzer M (1992). Immediate-early RNA 2.9 and early RNA 2.6 of bovine herpesvirus 1 are 3 coterminal and encode a putative zinc finger transactivator protein. Journal of Virology 66: 2763-2772.
222. Wu FY, Wang SE, Chen H, Wang L, Hayward SD and Hayward GS (2004). CCAAT/enhancer binding protein alpha binds to the Epstein-Barr virus (EBV) ZTA protein through oligomeric interactions and contributes to cooperative transcriptional activation of the ZTA promoter through direct binding to the ZII and ZIIB motifs during induction of the EBV lytic cycle. Journal of Virology 78: 4847-4865.
223. Wu SX, Zhu XP and Letchworth GJ (1998). Bovine herpesvirus 1 glycoprotein M forms a disulfide-linked heterodimer with the U(L)49.5 protein. Journal of Virology 72: 3029-3036.
224. Wuyckhuise L, Van Bosch J, Franken P, Hage J, Verhoeff J and Zimmer G (1994). The prevalence of infectious bovine rhinotracheitis (IBR) in the Netherlands. In: 18th World Buiatrics Congress, Bologna, Italy, pp. 1439-1442.
225. Xu Z, Maroney AC, Dobrzanski P, Kukekov NV and Greene LA (2001). The MLK family mediates c-Jun N-terminal kinase activation in neuronal apoptosis. Molecular and Cellular Biology 21: 4713-4724.
226. Yates WDG (1982). A review of infectious bovine rhinotracheitis, shipping fever pneumonia, and viral-bacterial synergism respiratory diesease of cattle. Canadian Journal of Comparative Medicine 46: 225-263.
227. Yoneyama M, Suhara W, Fukuhara M, Fukuda M, Nishida E and Fujita T (1998). Direct triggering of the type 1 interferon system by virus infection: activation of a transcription factors containing IRF-3 and CBP/p300. EMBO Journal 17: 1087-1095.
228. Yuang Y, Lowther W, Kellum M, Au WC, Lin R, Hiscott J and Pitha PM (1998). Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3. Proceedings of the National Academy of Sciences, USA 95: 9837-9842.
229. Zakhartchouk AN, Pyne C, Mutwiri GK, Papp Z, Baca-Estrada ME, Griebel P, Babiuk LA and Tikoo SK (1999). Mucosal immunization of calves with recombinant bovine adenovirus-3: induction of protective immunity to bovine herpesvirus-1. Journal of General Virology 80: 1263-1269.
230. Zhang Y and Jones C (2001). The bovine herpesvirus 1 immediate-early protein (bICP0) associates with histone deacetylase 1 to activate transcription. Journal of Virology 75: 9571-9578.
231. Zhang Y and Jones C (2005). Identification of functional domains within the bICP0 protein encoded by BHV-1. Journal of General Virology 86: 879-886.